View Older Stories
-
Globus Medical (GMED) Tops Q1 EPS by 20c ; Offers Guidance
-
Q1 MedTech quarterly preview: BTIG
-
Globus Medical (GMED) PT Raised to $112 at TD Cowen
-
Globus Medical (GMED) PT Raised to $114 at Needham
-
Globus Medical (GMED) PT Raised to $120 at Jefferies
-
Globus Medical (GMED) PT Raised to $115 at Truist Securities
-
Globus Medical (GMED) Tops Q4 EPS by 17c, provides guidance
-
Needham Upgrades Globus Medical (GMED) to Buy, 'Analysis Indicates Earnings Upside & Favorable Risk/Reward'
-
TD Cowen Starts Globus Medical (GMED) at Buy
-
Globus Medical (GMED) PT Raised to $112 at Canaccord Genuity
-
Globus Medical (GMED) Reiterated at Market Perform After 4Q25 Preannouncement
-
Globus Medical (GMED) PT Raised to $115 at Jefferies
-
After-hours movers: Lockheed Martin, Canadian Solar, Revolution Medicines and more
-
Globus Medical reports Q4 sales of $823.2M, beating estimates
-
Globus Medical (GMED) PT Raised to $90 at Stifel: Near-Tern Setup for Shares Solid
-
BofA’s six MedTech picks for 2026 on strong earnings growth
-
BTIG Reiterates Neutral Rating on Globus Medical (GMED)
-
Freedom Capital Markets Starts Globus Medical (GMED) at Hold
-
CFRA Downgrades Globus Medical (GMED) to Hold
-
Globus Medical (GMED) PT Raised to $105 at Truist Securities
-
Globus Medical (GMED) PT Raised to $90 at Piper Sandler
-
Needham Reiterates Hold Rating on Globus Medical (GMED)
-
BofA Securities Upgrades Globus Medical (GMED) to Buy
-
Truist Securities Upgrades Globus Medical (GMED) to Buy
-
Globus Medical (GMED) Tops Q3 EPS by 40c
-
Globus Medical launches ANTHEM elbow fracture plating system
-
Globus Medical wins patent case against Life Spine over spinal implants
-
Citizens JMP Reiterates Market Perform Rating on Globus Medical (GMED)
-
Globus Medical (GMED) PT Raised to $106 at Barclays
-
Globus Medical (GMED) Tops Q2 EPS by 10c; reaffirms guidance
-
Globus Medical (NYSE: GMED) PT Lowered to $88 at Jefferies
-
Needham Reiterates Hold Rating on Globus Medical (GMED)
-
Globus Medical names Keith Pfeil CEO, reports Q2 sales of $745.3 million
-
Globus Medical launches DuraPro oscillating surgical drill system
-
Piper Sandler on Globus Medical (GMED): 'Patience Required but We Maintain OW'
-
BTIG Downgrades Globus Medical (GMED) to Neutral, 'we see shares as unable to outperform'
-
Citizens JMP Reiterates Market Perform Rating on Globus Medical (GMED)
-
Globus Medical (GMED) Announces $500M Share Buyback
-
Globus Medical (GMED) PT Lowered to $78 at Oppenheimer
-
Globus Medical (GMED) PT Lowered to $68 at Truist Securities Following EPS Miss
-
Globus Medical (GMED) PT Lowered to $70 at Stifel
-
Globus Medical (GMED) PT Lowered to $77 at BTIG
-
Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance
-
Citizens JMP Reiterates Market Perform Rating on Globus Medical (GMED)
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
Globus Medical (GMED) completes acquisition of Nevro
-
Stifel Reiterates Buy Rating on Globus Medical (GMED)
-
Globus Medical (GMED) PT Lowered to $82 at Truist Securities
-
Globus Medical (GMED) Launches COHERE ALIF Spacer and Modulus ALIF Blades
-
RBC Capital: 'Opportunities Across MedTech Stocks'

